QT
RAPT

Quantbot Technologies’s RAPT Therapeutics RAPT Stock Holding History

Quantbot Technologies’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,413
Closed -$101K – 1826
2024
Q1 		$101K Buy
+1,413
New +$196K 0.01% 1170
2022
Q3 		– Sell
-734
Closed -$107K – 2002
2022
Q2 		$107K Buy
+734
New +$97.8K 0.01% 1125
2021
Q4 		– Sell
-75
Closed -$18K – 1839
2021
Q3 		$18K Buy
+75
New +$19.8K ﹤0.01% 1287

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Quantbot Technologies's RAPT Position: Q2 2024 in Review

Quantbot Technologies sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 1,413 shares — an estimated $101K sold.

Quantbot Technologies first reported a position in RAPT in Q3 2021 and held it in 3 quarters. The position peaked at $107K in Q2 2022. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • Quantbot Technologies reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,413 RAPT Therapeutics shares in Q2 2024, an estimated $101K.
  • Quantbot Technologies first reported a position in RAPT Therapeutics in Q3 2021 and held it in 3 quarters.
  • Quantbot Technologies's RAPT Therapeutics position peaked at $107K in Q2 2022.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.